Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Diabetes Intervention Program
NCT01470937Phase 4Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Feb 1998
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Acarbose with Placebo (2 arms). Primary endpoint: Progression of fasting glucose >140 mg/dL at 5 years. Started Feb 1998; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01470937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470937.